Sharpless named acting FDA commissioner
WASHINGTON — Dr. Norman “Ned” Sharpless, director of the National Cancer Institute, will become acting commissioner of the Food and…
March 12, 2019 by Chain Drug Review Featured Articles, Leading Headlines, Pharmacy
WASHINGTON — Dr. Norman “Ned” Sharpless, director of the National Cancer Institute, will become acting commissioner of the Food and…
March 12, 2019 by Chain Drug Review Leading Headlines, Pharmacy
ARLINGTON, Va. — The Healthcare Distribution Alliance recognized AbbVie US; AmerisourceBergen Corporation; Genentech, a Member of the Roche Group; McKesson Corporation…
March 12, 2019 by Bill Schiffner Pharmacy, Supplier News
OXNARD, Calif. – CURE Pharmaceutical Tuesday announced it has broadened its U.S. Drug Enforcement Administration (DEA) license as an authorized manufacturer of Schedule…
March 8, 2019 by Chain Drug Review Pharmacy, Supplier News
BALTIMORE — Lupin announced that it has received approval for its atorvastatin calcium tablets USP, 10 mg, 20 mg, 40 mg,…
March 8, 2019 by Chain Drug Review Leading Headlines, Pharmacy
ARLINGTON, Va. – Morning Consult Friday published an opinion piece by the National Association of Chain Drug Stores (NACDS) entitled…
March 8, 2019 by Chain Drug Review Leading Headlines, Pharmacy, Retail News
WINCHESTER, Va. — In its ongoing effort to help combat the nation’s opioid epidemic across the country, CVS Health announced Friday…
March 8, 2019 by Chain Drug Review Leading Headlines, Pharmacy
WASHINGTON — In the midst of a very important discussion around prescription drug pricing in Washington, D.C., CVS Health…
March 7, 2019 by Chain Drug Review Featured Articles, Leading Headlines, Pharmacy
WASHINGTON – An impressive force of 424 advocates from all 50 states reached every Congressional office during the 2019 National…